Study: Merck’s COVID-19 pill reduces hospitalization risk by 65%

[ad_1]

UNDATED (WKRC) – Merck’s COVID-19 drug appears to be helping people stay out of the hospital. A new study from India says the drug company’s anti-viral pill, Molnupiravir, reduced the risk of hospitalization by 65 percent. .

Sources

1/ https://Google.com/

2/ https://local12.com/news/nation-world/study-mercks-covid-19-pill-reduces-hospitalization-risk-by-65-coronavirus-pandemic-treatment-drug-molnupiravir-symptoms-scientists-research-scholarly-journal-virus-infection-conference-death-omicron-booster-vaccine-mask-india-cincinnati-ohio

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts